Investors expect Luyan Pharma Co.,Ltd.'s limited growth rate...
Investors expect Luyan Pharma Co.,Ltd.'s limited growth rates to continue, contributing to its low P/E ratio. The recent medium-term earnings trends, worse than market expectations, also play a part. Investors believe the potential for earnings improvement doesn't justify a higher P/E ratio.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000002955db50234ee4.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment